Proteomic blood profiling in mild, severe and critical COVID-19 patients

ABSTRACT: The purpose of this study is to explore the proteomic differences between mild, severe and critical COVID-19 positive patients. Blood protein profiling was performed on 59 COVID-19 mild (n=26), severe (n=9) or critical (n=24) cases and 28 controls using the OLINK inflammation, autoimmune, cardiovascular and neurology panels. Differential expression analysis was performed within and between disease groups to generate nine different analyses

ORGANISM(S): Human

SUBMITTER: Dr Hamel Patel 

PROVIDER: S-BSST416 | biostudies-other |

REPOSITORIES: biostudies-other